Ricardo Toshio Fujiwara Selected Research

Ricardo Toshio Fujiwara Research Topics

Disease

36	Infections 07/2022 - 03/2003
20	Visceral Leishmaniasis (Kala Azar) 12/2021 - 09/2005
8	Leishmaniasis 05/2017 - 03/2003
7	Inflammation (Inflammations) 07/2022 - 11/2011
7	Chagas Disease (American Trypanosomiasis) 01/2021 - 04/2010
6	Parasitic Diseases (Parasitic Disease) 01/2018 - 03/2011
5	Malaria 01/2017 - 02/2008
4	Ascariasis 01/2022 - 01/2018
4	Schistosomiasis mansoni 01/2021 - 01/2010
4	Hookworm Infections (Hookworm Infection) 01/2018 - 11/2011
3	Leprosy (Hansen's Disease) 01/2022 - 01/2017
2	Parasitemia 01/2021 - 01/2014
2	Schistosomiasis (Bilharziasis) 01/2018 - 04/2014
2	Vivax Malaria 01/2017 - 07/2012
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022
1	Helminthiasis (Helminthiases) 01/2022
1	Multiple Sclerosis 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Eosinophilia 11/2021
1	Myalgia 07/2021
1	Reinfection 01/2021
1	Neglected Diseases 01/2021
1	Hemolysis 01/2020
1	Convalescence 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Dog Diseases (Disease, Canine) 02/2015
1	Hyperplasia 01/2013
1	Ancylostomiasis 01/2013
1	Cysts 12/2012

Drug/Important Bio-Agent (IBA)

25	AntigensIBA 10/2021 - 09/2005
18	VaccinesIBA 01/2021 - 09/2005
16	CytokinesIBA 07/2022 - 03/2010
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2003
7	Immunoglobulin G (IgG)IBA 10/2021 - 03/2011
7	Peptides (Polypeptides)IBA 01/2021 - 01/2012
6	Recombinant ProteinsIBA 08/2021 - 01/2015
6	EpitopesIBA 05/2017 - 01/2011
4	Interleukin-17 (Interleukin 17)IBA 01/2022 - 07/2012
4	Interleukin-10 (Interleukin 10)IBA 01/2017 - 01/2015
4	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 02/2015 - 01/2014
3	ChemokinesIBA 01/2022 - 01/2017
3	Interleukin-12 (IL 12)IBA 04/2021 - 12/2013
3	AntibodiesIBA 08/2020 - 01/2012
3	Complement System Proteins (Complement)IBA 01/2020 - 01/2017
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2022 - 12/2013
2	Secretory Immunoglobulin A (SIgA)IBA 01/2022 - 11/2021
2	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2022 - 01/2017
2	KinesinsIBA 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 08/2020 - 12/2013
2	ImmunosorbentsIBA 07/2014 - 03/2011
2	SaponinsIBA 12/2013 - 01/2012
2	Immunoglobulin E (IgE)IBA 12/2013 - 01/2010
2	Synthetic Vaccines (Recombinant Vaccines)IBA 04/2013 - 03/2008
2	Immunoglobulin M (IgM)IBA 01/2012 - 03/2011
2	HLA-DR Antigens (HLA-DR)IBA 04/2011 - 09/2009
2	polyacrylamideIBA 03/2011 - 03/2003
1	Lipid NanoparticlesIBA 01/2022
1	Dimethyl FumarateIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	CathelicidinsIBA 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 07/2021
1	Interleukin-4 (Interleukin 4)IBA 04/2021
1	AnthelminticsIBA 01/2021
1	Interleukin-33IBA 01/2021
1	liposomal amphotericin B FDA Link 12/2018
1	Praziquantel (Biltricide)FDA Link 01/2018
1	Virulence Factors (Pathogenicity Factors)IBA 05/2017
1	Chemokine CCL5IBA 01/2017
1	HepcidinsIBA 01/2017
1	Interleukin-27 (Interleukin 27)IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Liposomes (Liposome)IBA 02/2015
1	Immunologic Factors (Immunomodulators)IBA 02/2015
1	SphingomyelinsIBA 02/2015
1	CholesterolIBA 02/2015
1	Mitogen-Activated Protein KinasesIBA 02/2015
1	Mitogen-Activated Protein Kinase 3IBA 02/2015
1	Surface Antigens (Surface Antigen)IBA 01/2015
1	Cathepsin LIBA 01/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2014
1	EnzymesIBA 07/2014
1	PeroxiredoxinsIBA 01/2014
1	Thomsen-Friedenreich antibodiesIBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Prednisolone (Predate)FDA LinkGeneric 01/2013
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2013
1	liriodenineIBA 12/2012
1	AlkaloidsIBA 12/2012
1	NaphthoquinonesIBA 12/2012
1	incomplete Freund's adjuvantIBA 01/2012

Therapy/Procedure

3	Therapeutics 01/2022 - 11/2011
2	Immunomodulation 01/2013 - 11/2011
1	Drug Therapy (Chemotherapy) 01/2021
1	Mass Drug Administration 01/2021
1	Electroacupuncture 02/2018